KELLY RASMUSSEN: Open Payments
NPI 1023328226 · ROCKFORD, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$524 in 25 payments from 12 companies in 2025. Trend: 2023 $490 · 2024 $189 · 2025 $524
Food & beverage: $504Education: $20
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 5 | $89 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $66 |
| Merck Sharp & Dohme LLC | 3 | $56 |
| Amgen Inc. | 2 | $51 |
| SCPHARMACEUTICALS INC. | 2 | $49 |
| Daiichi Sankyo Inc. | 2 | $45 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| ABIOMED | 1 | $33 |
| Esperion Therapeutics, Inc. | 2 | $30 |
| Abbott Laboratories | 1 | $28 |
Products named: JARDIANCE, VERQUVO, ELIQUIS, REPATHA, FUROSCIX, INJECTAFER, Kerendia, CAMZYOS.
Industry payments across IL — which companies pay providers there.
